Search research articles
Contact Us
Filters
Showing results (41-50 of 94) with videos related to
Page
of 10
Sort By:
The Prostate
|
April 15, 2008
Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis
Rebecca A Marks, Shaobo Zhang, Rodolfo Montironi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 30, 2019
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis
Seth Walker, Patrick Flume, John McNamara, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 10, 2023
All-Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B-β-TrCP-SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy
Lei Li, Rui Zhu, Honghong Zhou, et al.
The New England Journal of Medicine
|
August 11, 2021
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Kashif Ali, Gary Berman, Honghong Zhou, et al.
Eclinicalmedicine
|
August 2, 2024
Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial
Amparo L Figueroa, Kashif Ali, Gary Berman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Annals of Internal Medicine
|
July 5, 2022
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Dean Follmann, Holly E Janes, Olive D Buhule, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials
Uma Siangphoe, Lindsey R Baden, Hana M El Sahly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 11, 2023
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial
Nima S Hejazi, Xiaoying Shen, Lindsay N Carpp, et al.
Cell & Bioscience
|
November 27, 2025
Deciphering the epigenomic regulatory variations reveals function diversity in adipose lineage among different adipose depots of pigs
Daoyuan Wang, Renzhuo Kuang, Mingyang Hu, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 94) with videos related to
Sort By:
Page
of 10
The Prostate
|
April 15, 2008
Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis
Rebecca A Marks, Shaobo Zhang, Rodolfo Montironi, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
June 30, 2019
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis
Seth Walker, Patrick Flume, John McNamara, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 10, 2023
All-Trans Retinoic Acid Promotes a Tumor Suppressive OTUD6B-β-TrCP-SNAIL Axis in Esophageal Squamous Cell Carcinoma and Enhances Immunotherapy
Lei Li, Rui Zhu, Honghong Zhou, et al.
The New England Journal of Medicine
|
August 11, 2021
Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Kashif Ali, Gary Berman, Honghong Zhou, et al.
Eclinicalmedicine
|
August 2, 2024
Safety and durability of mRNA-1273-induced SARS-CoV-2 immune responses in adolescents: results from the phase 2/3 TeenCOVE trial
Amparo L Figueroa, Kashif Ali, Gary Berman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 7, 2014
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer
Joe J Stephenson, John Nemunaitis, Anil A Joy, et al.
Annals of Internal Medicine
|
July 5, 2022
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial
Dean Follmann, Holly E Janes, Olive D Buhule, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 21, 2022
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials
Uma Siangphoe, Lindsey R Baden, Hana M El Sahly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
October 11, 2023
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial
Nima S Hejazi, Xiaoying Shen, Lindsay N Carpp, et al.
Cell & Bioscience
|
November 27, 2025
Deciphering the epigenomic regulatory variations reveals function diversity in adipose lineage among different adipose depots of pigs
Daoyuan Wang, Renzhuo Kuang, Mingyang Hu, et al.
Page
of 10